Wednesday, August 29, 2012

Prasugrel Versus Clopidogrel For ACS Patients Managed Without Revascularisation: The TRILOGY ACS Study

The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the prevention of death, myocardial infarction or stroke...

via Medical News Today

No comments:

Post a Comment